Global Injectable Drug Delivery Market Growing at 12% of Compound Rate to Reach $ 547.8 Billion by 2020

Press Release   •   May 23, 2016 10:05 EDT

Injectable drug delivery offers a promising alternative for the delivery of drugs that are ineffective when administered orally. Injectable drug delivery is aimed to maximize patient compliance and reduce the frequency of dosage administration without compromising the effectiveness of the treatment.

Complete report on Injectable Drug Delivery Market spread across 241 pages, Profiling 10 Companies and supported with 217 Tables and 47 Figures is now available at http://www.reportsnreports.com/reports/232484-injectable-drug-delivery-market-by-formulations-liposomes-microspheres-nanoparticles-devices-disposables-reusable-fillable-prefilled-pen-needle-free-auto-injectors-therapeutics-diabetes-oncology-global-forecasts-to-2017.html .

The major factors responsible for the growth of the injectable drug delivery market are the rising prevalence of chronic diseases, growth of the biologics market, rising demand for self-injection devices, and technological advancements. Owing to these factors, the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes is increasing.

Premium Insights

1 Injectable Drug Delivery Market, By Formulation

2 Injectable Drug Delivery Market, By Usage Pattern

3 Injectable Drug Delivery Market, By Mode of Administration

4 Injectable Drug Delivery Market, By Therapeutic Application

5 Geographical Snapshot

The injectable drug delivery market is expected to reach $574.8 Billion by 2020 from $326.2 Billion in 2015, growing at a CAGR of 12.0% from 2015 to 2020. Based on type, the market is segmented into devices and formulations. The devices market is further segmented into conventional injection devices, self-injections, and other devices. The formulations market is further segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations.

Sample copy of this research is available now

http://www.reportsnreports.com/contacts/requestsample.aspx?name=232484 .

On the basis of mode of administration, the market is segmented into skin, organs, central nervous system, and circulatory/musculoskeletal system. On the basis of end user, the market is segmented into hospitals/clinics, home care setting, research laboratories, pharma and biotech companies, and other end users.

Key players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International, Inc. (U.S.), Gerresheimer AG (Germany), Pfizer, Inc. (U.S.), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), and Eli Lilly and Company (U.S.).

Click now for more Details, Quiries and Discount, Other Information on this study “Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, HomeCare Setting) - Global Forecast to 2020” research @ http://www.reportsnreports.com/contacts/discount.aspx?name=232484 .

On the basis of therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other diseases. On the basis of usage pattern, the market is segmented into curative care, immunization, and others.

Asia is expected to be the fastest-growing country in the injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.

Explore more reports on Medical Devices at www.reportsnreports.com/market-research/medical-devices/ .

About Us:

ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441